A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumors

Constantinos Alifieris,Kyriakos Orfanakos,Aristina Papanota,George P. Stathopoulos,Nikolaos M. Sitaras,Dimitrios T. Trafalis

A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumors

2017

Constantinos Alifieris
Kyriakos Orfanakos
Aristina Papanota
George P. Stathopoulos
Nikolaos M. Sitaras
Dimitrios T. Trafalis

Purpose This is a single-center uncontrolled retrospective study to evaluate the efficacy and safety of the biosimilar epoetin zeta after approval in chemotherapy-induced anemia (CIA).

Keywords:

Erythropoietin
Biosimilar
Immunology
Uncontrolled Study
Epoetin Zeta
Anemia
Retrospective cohort study
Intensive care medicine
Chemotherapy
Internal medicine
Biology
Diabetes mellitus
Oncology
Surgery
Hematology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations